However, it appears that the glucose-lowering and insulin-sensiti

However, it appears that the glucose-lowering and insulin-sensitizing effect of osteocalcin is not mediated by an increment in the plasma adiponectin level in humans. Acknowledgment This research was supported by the Program of Kyung Hee University for the Young Researcher of Medical Science (KHU-20091457). Conflicts of interest None. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. References 1. Lee NK, Sowa H, Hinoi E et al (2007) Endocrine regulation

of energy metabolism by the skeleton. Cell 130:456–469PubMedCrossRef 2. Im JA, Yu BP, Jeon JY, Kim SH (2008) RSL 3 Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 396:66–69PubMedCrossRef 3. Kanazawa I, Yamaguchi T, Yamamoto M et al (2009) Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 94:45–49PubMedCrossRef 4. Zhou

M, Ma X, Li H et al (2009) Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 161:723–729PubMedCrossRef 5. Fernandez-Real JM, Izquierdo M, Ortega F et al (2009) The relationship Barasertib chemical structure of serum osteocalcin concentration crotamiton to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 94:237–2459PubMedCrossRef 6. Kindblom JM, Ohlsson C, Ljunggren O et al (2008) Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res

24:785–Caspase inhibitor 791CrossRef 7. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B (2009) Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 94:827–832PubMedCrossRef 8. Hwang YC, Jeong IK, Ahn KJ, Chung HY (2009) The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diab Metab Res Rev 25:768–772CrossRef 9. Shea MK, Gundberg CM, Meigs JB et al (2009) Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 90:1230–1235PubMedCrossRef 10. Winhofer Y, Handisurya A, Tura A et al (2010) Osteocalcin is related to enhanced insulin secretion in gestational diabetes. Diabetes Care 33:139–143PubMedCrossRef 11. Mari A, Ahrén B, Pacini G (2005) Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care 8:529–533PubMedCrossRef 12. Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 17:305–322PubMedCrossRef 13.

Comments are closed.